Organigram Holdings reported CAD140.98M in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
Acasti Pharma USD 1000 261.04M Dec/2024
Akebia Therapeutics USD 265.42M 199K Dec/2025
Alaunos Therapeutics USD 2.49M 108K Jun/2026
Aurora Cannabis CAD 63.31M 4.36M Jun/2026
Canopy Growth CAD 422.07M 53.78M Mar/2026
Cronos Group USD 370.73M 5.53M Jun/2026
Dianthus Therapeutics USD 54.8M 215.59K Jun/2026
Ionis Pharmaceuticals USD 166.41M 773K Sep/2026
IQVIA Holdings USD 164.8M 200K Sep/2026
Knight Therapeutics CAD 99.68M 24.66K Sep/2025
Moderna USD 391M 2M Sep/2025
Organigram Holdings CAD 140.98M 4.51M Jun/2026
Organon & Co USD 262.62M 13K Sep/2026
Revvity USD 111.59M 43K Sep/2026
Tectonic Therapeutic USD 19.24M 404.78K Jun/2026
Tilray USD 116.52M 5.01M Sep/2025
Viatris USD 1.15B 8.79M Sep/2026
Xeris Pharmaceuticals USD 173.59M 1.03M Jun/2026